TRANSCODE THERAPEUTICS INC (RNAZ) Stock Cash Flow
NASDAQ:RNAZ - US89357L4023 - Common Stock
10.72 USD
-0.25 (-2.28%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.60M | -16.75M | -18.55M | -17.57M | -6.84M | |||
| Depreciation Amortization | 315.00K | 534.90K | 123.50K | 98.60K | 42.50K | |||
| Change In Working Capital | -1.66M | -351.50K | -1.08M | 1.34M | 401.90K | |||
| Interest Paid | 9.50K | 16.60K | 32.90K | 37.10K | 17.90K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 11.59M | 3.24M | 1.43M | 364.80K | 1.13M | |||
| OPERATING CASH FLOW | -14.35M | -13.34M | -18.07M | -15.76M | -5.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -21.80K | -35.60K | -100.90K | -254.80K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 3.00K | |||
| INVESTING CASH FLOW | N/A | -21.80K | -35.60K | -100.90K | -251.80K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 18.38M | 16.40M | 15.91M | 6.00K | 26.35M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -831.70K | |||
| FINANCING CASH FLOW | 18.38M | 16.40M | 15.91M | 6.00K | 25.52M | |||
| CHANGE IN CASH | 4.02M | 3.04M | -2.20M | -15.86M | 20.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.35M | -13.34M | -18.07M | -15.76M | -5.27M | |||
| Capital Expenditure | N/A | -21.80K | -35.60K | -100.90K | -254.80K | |||
| FREE CASH FLOW | -14.36M | -13.36M | -18.11M | -15.86M | -5.52M | |||
All data in USD